Correlation Between MagnaChip Semiconductor and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both MagnaChip Semiconductor and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MagnaChip Semiconductor and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MagnaChip Semiconductor and Entero Therapeutics,, you can compare the effects of market volatilities on MagnaChip Semiconductor and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MagnaChip Semiconductor with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MagnaChip Semiconductor and Entero Therapeutics,.
Diversification Opportunities for MagnaChip Semiconductor and Entero Therapeutics,
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MagnaChip and Entero is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding MagnaChip Semiconductor and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and MagnaChip Semiconductor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MagnaChip Semiconductor are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of MagnaChip Semiconductor i.e., MagnaChip Semiconductor and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between MagnaChip Semiconductor and Entero Therapeutics,
Allowing for the 90-day total investment horizon MagnaChip Semiconductor is expected to generate 0.24 times more return on investment than Entero Therapeutics,. However, MagnaChip Semiconductor is 4.2 times less risky than Entero Therapeutics,. It trades about -0.05 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.06 per unit of risk. If you would invest 923.00 in MagnaChip Semiconductor on September 2, 2024 and sell it today you would lose (491.00) from holding MagnaChip Semiconductor or give up 53.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
MagnaChip Semiconductor vs. Entero Therapeutics,
Performance |
| Timeline |
| MagnaChip Semiconductor |
| Entero Therapeutics, |
MagnaChip Semiconductor and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MagnaChip Semiconductor and Entero Therapeutics,
The main advantage of trading using opposite MagnaChip Semiconductor and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MagnaChip Semiconductor position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| MagnaChip Semiconductor vs. NXP Semiconductors NV | MagnaChip Semiconductor vs. GSI Technology | MagnaChip Semiconductor vs. MaxLinear | MagnaChip Semiconductor vs. Texas Instruments Incorporated |
| Entero Therapeutics, vs. Tff Pharmaceuticals | Entero Therapeutics, vs. Eliem Therapeutics | Entero Therapeutics, vs. Inhibrx | Entero Therapeutics, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |